查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463112

沙眼治疗市场、占有率、规模、趋势、行业分析报告：依给药途径、依药物类别、依地区、依细分市场、预测，2024-2032 年

Trachoma Treatment Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral and Topical); By Drug Class; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球沙眼治疗市场预计将达到9.2443亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

沙眼盛行率的快速增加以及私人和公共医疗保健组织的普及以提高公众对沙眼及其治疗选择的认识是推动市场成长的突出因素。 例如，2024年1月，生活在活动性沙眼高发地区的人口估计到2023年约为1.16亿，超过150万人需要接受倒睫手术。

此外，为了遏制可预防性失明的蔓延，世界各地正在增加有利的监管政策和激励计划，以促进新沙眼治疗方法的开发，进一步推动市场成长。 例如，2024年2月，联邦政府宣布启动一项新计划，消除沙眼、疟疾、丝虫病、盘尾丝虫病和疟疾等疾病。

此外，由于沙眼在中东和非洲和亚太地区的欠发达经济体和发展中国家最为普遍，因此越来越需要显着改善医疗基础设施，全球和医疗保健公司正在帮助扩大其在新兴市场的业务。 随着公司和政府增加对医疗基础设施的投资并使更多患者更容易获得医疗服务，对有效沙眼治疗方案的需求将呈指数级增长。 例如，根据国际贸易署的数据，2024年1月，马来西亚政府持续加强医疗保健领域，将国家医疗保健预算从2022年的710万美元增加到790万美元。

能够远端诊断和治疗沙眼的数位健康技术和远距医疗正在世界各地兴起，为提供沙眼治疗解决方案的公司创造了利润丰厚的机会。 此外，专注于开发沙眼预防产品的公司，包括卫生和环境卫生解决方案以及比传统解决方案更容易管理且更实惠的新药物，可能在市场上具有很高的竞争优势。

沙眼治疗市场报告亮点

口服药物由于具有全身性覆盖、降低污染风险和东方给药等特点，占了显着的占有率。

大环内酯类药物以其价格实惠、抗药性细菌少、易取得、疗程短等特征占了较大的市场占有率。

北美凭藉其成熟的医疗基础设施和不断增加的开发新解决方案的研发活动而在全球市场占主导地位。

主要市场参与者包括艾尔建公司(Allergan Inc.)、礼来公司(Eli Lilly and Company)、拜耳公司(Bayer AG)、Bausch Health Companies、Cipla、诺华公司(Novartis AG)、Arbor Pharmaceuticals 和艾伯维(AbbVie)。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第四章全球沙眼治疗市场洞察

  • 沙眼治疗市场 - 产业概况
  • 沙眼治疗市场动态
    • 推动者和机会
      • 沙眼流行和疾病预防意识的提高推动了成长
      • 医疗保健成本的改善和治疗方法的进步推动市场成长
    • 抑制因素和课题
      • 治疗费用高且缺乏认识
  • 杵分析
  • 沙眼治疗产业趋势
  • 价值链分析
  • 新冠肺炎 (COVID-19) 影响分析

第 5 章依管理途径划分的全球市场

  • 主要发现
  • 简介
  • 口头
  • 外部使用

第 6 章依药物类别划分的世界市场

  • 主要发现
  • 简介
  • 大环内酯
  • 四环素
  • 眼科抗感染药
  • 磺酰胺

第 7 章依地区划分的世界市场

  • 主要发现
  • 简介
    • 2019-2032 年沙眼治疗市场评估（依地区）
  • 沙眼治疗市场 - 北美
    • 北美：沙眼治疗市场，依药物类别，2019-2032 年
    • 北美：沙眼治疗市场，依给药途径划分，2019-2032 年
    • 沙眼治疗市场 - 美国
    • 沙眼治疗市场 - 加拿大
  • 沙眼治疗市场 - 欧洲
    • 欧洲：沙眼治疗市场，依药物类别，2019-2032 年
    • 欧洲：沙眼治疗市场（依给药途径），2019-2032 年
    • 沙眼治疗市场 - 英国
    • 沙眼治疗市场 - 法国
    • 沙眼治疗市场 - 德国
    • 沙眼治疗市场 - 义大利
    • 沙眼治疗市场 - 西班牙
    • 沙眼治疗市场 - 荷兰
    • 沙眼治疗市场 - 俄罗斯
  • 沙眼治疗市场 - 亚太地区
    • 亚太地区：沙眼治疗市场，依药物类别，2019-2032 年
    • 亚太地区：沙眼治疗市场，依给药途径划分，2019-2032 年
    • 沙眼治疗市场 - 中国
    • 沙眼治疗市场 - 印度
    • 沙眼治疗市场 - 马来西亚
    • 沙眼治疗市场 - 日本
    • 沙眼治疗市场 - 印尼
    • 沙眼治疗市场 - 韩国
  • 沙眼治疗市场 - 中东和非洲
    • 中东与非洲：沙眼治疗市场（依药物类别），2019-2032 年
    • 中东与非洲：沙眼治疗市场，依给药途径划分，2019-2032 年
    • 沙眼治疗市场 - 沙乌地阿拉伯
    • 沙眼治疗市场 - 阿联酋
    • 沙眼治疗市场 - 以色列
    • 沙眼治疗市场 - 南非
  • 沙眼治疗市场 - 拉丁美洲
    • 拉丁美洲：沙眼治疗市场，依药物类别，2019-2032 年
    • 拉丁美洲：沙眼治疗市场，依给药途径划分，2019-2032 年
    • 沙眼治疗市场 - 墨西哥
    • 沙眼治疗市场 - 巴西
    • 沙眼治疗市场 - 阿根廷

第八章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 合作/协作/合约/出版物

第九章公司简介

  • Abbott Laboratories
  • AbbVie Inc.
  • Allergan Inc
  • Arbor Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • Bayer AG.
  • Cipla Inc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
Product Code: PM4785

The global trachoma treatment market size is expected to reach USD 924.43 million by 2032, according to a new study by Polaris Market Research. The report "Trachoma Treatment Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral and Topical); By Drug Class; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rapid increase in the prevalence of trachoma and its proliferation among private and public healthcare organizations to raise awareness about trachoma and its treatment options among the general public are prominent factors driving the market growth. For instance, in January 2024, the number of people living in districts with a high prevalence of active trachoma was estimated at around 116 million in 2023, and over 1.5 million people required surgery for trichiasis.

In addition, a growing number of favorable regulatory policies and incentive programs promoting the development of new trachoma treatments to control the spread of preventable blindness worldwide, further boosting market growth. For instance, in February 2024, The Federal government announced the launch of its new program to eliminate diseases, including trachoma, malaria, filariasis, onchocerciasis, and goehelminthiasis

Furthermore, as trachoma is most prevalent is under-developed or developing economies of MEA and APAC region, thereby the need for significant improvements in healthcare infrastructure is growing and encouraging global healthcare companies to expand their market presence in these emerging and untapped markets. With companies and governments increasingly investing in healthcare infrastructure development and making healthcare services easily accessible to a larger patient population, the demand for effective trachoma treatment options will boost drastically. For instance, according to the International Trade Administration, in January 2024, the Malaysian government continued to strengthen its healthcare sector, increasing the national budget for healthcare to USD 7.9 million compared to USD 7.1 million in 2022.

The emergence of digital health technologies and telemedicine across the globe, which enables the remote diagnosis and treatment of trachoma, is presenting a lucrative opportunity for companies providing trachoma treatment solutions. Also, companies focusing on the development of products for trachoma prevention including hygiene and sanitation solutions and new drugs that are easy to administer and affordable as compared to conventional solutions, are likely to gain a competitive edge in the market.

Trachoma Treatment Market Report Highlights

Oral segment accounted for a noteworthy share, which is attributed to its characteristics, including systemic coverage, reduced contamination risk, and east administration

The macrolides segment held a significant share due to its affordability, reduced resistance, easy availability, and shorter treatment time

North America dominated the global market on account of well-established healthcare infrastructure and rising R&D activities for the development of new solutions

The key market players include Allergan Inc., Eli Lilly and Company, Bayer AG, Bausch Health Companies, Cipla, Novartis AG, Arbor Pharmaceuticals, and AbbVie

Polaris Market Research has segmented the trachoma treatment market report based on route of administration, drug class, and region:

Trachoma Treatment, Route of Administration Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral
  • Topical

Trachoma Treatment, Drug Class Outlook (Revenue - USD Million, 2019 - 2032)

  • Macrolides
  • Tetracycline
  • Ophthalmic Anti-Infective
  • Sulfonamides

Trachoma Treatment, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Trachoma Treatment Market Insights

  • 4.1. Trachoma Treatment Market - Industry Snapshot
  • 4.2. Trachoma Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of trachoma and awareness about disease prevention to drive growth
      • 4.2.1.2. Improvements in healthcare expenditure and advancements in treatments to boost market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost associated with treatment and lack of awareness
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Trachoma Treatment Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Trachoma Treatment Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Trachoma Treatment, by Route of Administration, 2019-2032 (USD Million)
  • 5.3. Oral
    • 5.3.1. Global Trachoma Treatment Market, by Oral, by Region, 2019-2032 (USD Million)
  • 5.4. Topical
    • 5.4.1. Global Trachoma Treatment Market, by Topical, by Region, 2019-2032 (USD Million)

6. Global Trachoma Treatment Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • 6.3. Macrolides
    • 6.3.1. Global Trachoma Treatment Market, by Macrolides, by Region, 2019-2032 (USD Million)
  • 6.4. Tetracycline
    • 6.4.1. Global Trachoma Treatment Market, by Tetracycline, by Region, 2019-2032 (USD Million)
  • 6.5. Ophthalmic Anti-infective
    • 6.5.1. Global Trachoma Treatment Market, by Ophthalmic Anti-infective, by Region, 2019-2032 (USD Million)
  • 6.6. Sulfonamides
    • 6.6.1. Global Trachoma Treatment Market, by Sulfonamides, by Region, 2019-2032 (USD Million)

7. Global Trachoma Treatment Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Trachoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Trachoma Treatment Market - North America
    • 7.3.1. North America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
    • 7.3.2. North America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.3.3. Trachoma Treatment Market - U.S.
      • 7.3.3.1. U.S.: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.3.4. Trachoma Treatment Market - Canada
      • 7.3.4.1. Canada: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • 7.4. Trachoma Treatment Market - Europe
    • 7.4.1. Europe: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
    • 7.4.2. Europe: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.3. Trachoma Treatment Market - UK
      • 7.4.3.1. UK: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.4. Trachoma Treatment Market - France
      • 7.4.4.1. France: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.4.2. France: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.5. Trachoma Treatment Market - Germany
      • 7.4.5.1. Germany: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.6. Trachoma Treatment Market - Italy
      • 7.4.6.1. Italy: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.7. Trachoma Treatment Market - Spain
      • 7.4.7.1. Spain: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.8. Trachoma Treatment Market - Netherlands
      • 7.4.8.1. Netherlands: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.9. Trachoma Treatment Market - Russia
      • 7.4.9.1. Russia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • 7.5. Trachoma Treatment Market - Asia Pacific
    • 7.5.1. Asia Pacific: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.3. Trachoma Treatment Market - China
      • 7.5.3.1. China: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.3.2. China: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.4. Trachoma Treatment Market - India
      • 7.5.4.1. India: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.4.2. India: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.5. Trachoma Treatment Market - Malaysia
      • 7.5.5.1. Malaysia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.6. Trachoma Treatment Market - Japan
      • 7.5.6.1. Japan: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.7. Trachoma Treatment Market - Indonesia
      • 7.5.7.1. Indonesia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.8. Trachoma Treatment Market - South Korea
      • 7.5.8.1. South Korea: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • 7.6. Trachoma Treatment Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.6.3. Trachoma Treatment Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.6.4. Trachoma Treatment Market - UAE
      • 7.6.4.1. UAE: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.6.5. Trachoma Treatment Market - Israel
      • 7.6.5.1. Israel: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.6.6. Trachoma Treatment Market - South Africa
      • 7.6.6.1. South Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • 7.7. Trachoma Treatment Market - Latin America
    • 7.7.1. Latin America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.7.3. Trachoma Treatment Market - Mexico
      • 7.7.3.1. Mexico: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.7.4. Trachoma Treatment Market - Brazil
      • 7.7.4.1. Brazil: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.7.5. Trachoma Treatment Market - Argentina
      • 7.7.5.1. Argentina: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. AbbVie Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Allergan Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Arbor Pharmaceuticals Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Bausch Health Companies Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Bayer AG.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Cipla Inc
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Eli Lilly and Company
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. F. Hoffmann-La Roche Ltd
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Merck & Co. Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Mylan NV
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Novartis AG
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Pfizer Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Sanofi SA
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development

List of Tables

  • Table 1 Global Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 2 Global Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 3 Trachoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 5 North America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 6 U.S.: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 7 U.S.: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 8 Canada: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 9 Canada: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 10 Europe: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 11 Europe: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 12 UK: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 13 UK: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 14 France: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 15 France: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 16 Germany: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 17 Germany: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 18 Italy: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 19 Italy: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 20 Spain: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 21 Spain: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 22 Netherlands: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 23 Netherlands: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 24 Russia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 25 Russia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 28 China: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 29 China: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 30 India: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 31 India: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 32 Malaysia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 33 Malaysia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 34 Japan: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 35 Japan: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 36 Indonesia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 37 Indonesia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 38 South Korea: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 39 South Korea: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 44 UAE: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 45 UAE: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 46 Israel: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 47 Israel: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 48 South Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 49 South Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 50 Latin America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 51 Latin America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 52 Mexico: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 53 Mexico: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 54 Brazil: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 55 Brazil: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 56 Argentina: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 57 Argentina: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Trachoma Treatment Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Drug Class
  • Figure 7 Global Trachoma Treatment Market, by Drug Class, 2022 & 2032 (USD Million)
  • Figure 8 Market by Route of Administration
  • Figure 9 Global Trachoma Treatment Market, by Route of Administration, 2022 & 2032 (USD Million)
  • Figure 10 Trachoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Trachoma Treatment Market